Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04624399 |
| Title | Phase 2 Study of Neoadjuvant Immune Checkpoint Inhibitors in Urothelial Cancer (ABACUS-2) |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Queen Mary University of London |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Sheffield Teaching Hospitals NHS Foundation Trust | Sheffield | South Yorkshire | S5 7AU | United Kingdom | Details | |
| Clatterbridge Cancer Centre NHS Foundation Trust | Liverpool | United Kingdom | Details | |||
| Barts and London Hospital NHS Trust | London | United Kingdom | Details | |||
| University College London Hospitals NHS Foundation Trust | London | United Kingdom | Details | |||
| Oxford University Hospitals NHS Foundation Trust | Oxford | United Kingdom | Details | |||
| Southampton General Hospital | Southampton | United Kingdom | Details |